- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chemotherapy-induced neutropenia
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Pegfilgrastim – November 2019
Pegfilgrastim: Injection 6 mg in 0.6 mL single use pre-filled syringe; Ziextenzo®
Last updated
6 March 2020